Immune Evasion Mechanisms of Neurovirulent Alphaviruses
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
批准号:
7372970
负责人:
Mark T Heise
金额:
$28.8万
依托单位国家:
美国
项目类别:
财政年份:
2007
资助国家:
美国
项目状态:
已结题
起止时间:
2007-12-01 至 2012-11-30
关键词:
AdultAffectAlphavirusAlphavirus InfectionsAttenuatedCellsCleaved cellCulicidaeDevelopmentDiseaseEncephalitisEncephalitis VirusesEndopeptidasesEquus caballusEventGenerationsGenetic TranscriptionGoalsHealthHumanImmuneImmune responseImmune systemIn VitroInfectionInfectious ArthritisIntegration Host FactorsInterferon Type IInterferonsLaboratoriesMediatingModelingMolecularMusMutationNonstructural ProteinNumbersOpen Reading FramesPathogenesisPathway interactionsPeptide HydrolasesPhenotypePolyproteinsPositioning AttributeProcessRNARNA CapsRNA VirusesRNA chemical synthesisRangeRegulationRoleRoss river virusSemliki forest virusShapesSindbis VirusSystemTimeTranslationsViralViral Nonstructural ProteinsVirulenceVirulentVirusWorkbasehuman diseaseimmunogenicimprovedin vivoneurovirulencepathogenprotein expressionresearch studyresponsesensortherapeutic vaccinetraitvaccine deliveryvectorviral RNA
中文摘要
描述(由申请人提供):甲病毒可引起从感染性关节炎到致死性脑炎等疾病,是人类疾病的重要原因。虽然甲病毒感染的分子发病机制已经被广泛研究,但对于这些病毒如何与宿主免疫反应相互作用和逃避宿主免疫反应的了解相对较少。成年小鼠Sindbis病毒AR86株神经毒性研究我们的实验室已经在病毒非结构蛋白编码区确定了成年小鼠神经毒性的几个决定因素。其中一个决定因子位于nsP1 538,与宿主I型IFN系统相互作用,因为在体内和体外,在该位置具有衰减突变的病毒比野生型病毒诱导更多的I型IFN。进一步分析表明,AR86非结构蛋白能够通过特异性干扰细胞质RNA传感器RIG-I,直接干扰RIG-I介导的I型IFN诱导。对RIG-I依赖性IFN诱导通路的特异性拮抗是甲病毒对I型干扰素系统特异性拮抗的第一个证据。因此,我们提出了以下研究:1)表征病毒非结构蛋白拮抗RIG-I功能的机制;2)确定I型IFN诱导途径中的其他步骤是否也被病毒非结构蛋白靶向;3)确定哪些非结构蛋白或多蛋白前体介导RIG-I拮抗。4)确定nsP1 538的毒力决定因子与RIG-I/Mda5/MAVS干扰素诱导通路之间的相互作用是否有助于AR86对I型IFN诱导的调控,并随后对病毒毒力产生影响。这项工作有可能通过剖析这些重要的人类病原体与宿主先天免疫系统相互作用的机制,大大提高我们对甲病毒发病机制的理解。甲病毒是对人类健康的重大新威胁,对这些病毒如何与宿主先天免疫反应相互作用和破坏的进一步了解可能有助于开发针对这些病原体的改进疫苗/治疗方法。此外,由于基于阿尔法病毒的载体正在开发中,作为疫苗递送平台,对这些病毒如何与先天免疫系统相互作用的了解增加,可能导致产生更安全和更具免疫原性的载体。
英文摘要
DESCRIPTION (provided by applicant): Alphaviruses, which can cause diseases ranging from infectious arthritis to lethal encephalitis, are a significant cause of human disease. Though the molecular pathogenesis of alphavirus infections has been extensively studied, relatively little is known about how these viruses interact with and evade the host immune response. In studying the adult mouse neurovirulent AR86 strain of Sindbis virus; our laboratory has identified several determinants of adult mouse neurovirulence within the viral nonstructural protein coding region. One of these determinants, at nsP1 538, interacts with the host type I IFN system, since viruses with an attenuating mutation at this position induce significantly more type I IFN than the wild type virus in vivo and in vitro. Further analysis demonstrated that the AR86 nonstructural proteins are able to directly interfere with RIG-I mediated type I IFN induction by specifically interfering with the cytoplasmic RNA sensor, RIG-I. The demonstration of specific antagonism of the RIG-I dependent IFN induction pathway represents the first evidence for specific antagonism of the type I interferon system by alphaviruses. Therefore, studies are proposed to 1) characterize the mechanism(s) by which the viral nonstructural proteins antagonize RIG- I function, 2) determine whether other steps in the type I IFN induction pathway are also targeted by the viral nonstructural proteins, 3) determine which nonstructural proteins or polyprotein precursors mediate the RIG-I antagonism, and 4) determine whether interactions between the virulence determinant at nsP1 538 and the RIG-I/Mda5/MAVS interferon induction pathway contribute to the regulation of type I IFN induction by AR86, with subsequent effects on viral virulence. This work has the potential to significantly advance our understanding of alphavirus pathogenesis by dissecting the mechanisms by which these important human pathogens interact with the host innate immune system. Alphaviruses represent a significant emerging threat to human health, and an increased understanding of how these viruses interact with and subvert the host innate immune response is likely to assist in the development of improved vaccines/therapeutics against these pathogens. Furthermore, since alphavirus-based vectors are in development as vaccine delivery platforms, the increased understanding of how these viruses interact with the innate immune system is likely to result in the generation of safer and more immunogenic vectors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of Broad Spectrum Direct Acting Antivirals Against Emerging Alphaviruses
-
批准号:10513688
-
项目类别:
-
资助金额:$710.04万
-
财政年份:2022
-
负责人:Mark T Heise
-
依托单位:
TRIM Interactions with Arthritic Alphaviruses
-
批准号:8415508
-
项目类别:
-
资助金额:$18.19万
-
财政年份:2012
-
负责人:Mark T Heise
-
依托单位:
Systems Immunogenetics of Influenza Virus Infection in the Collaborative Cross
-
批准号:10238910
-
项目类别:
-
资助金额:$42.09万
-
财政年份:2012
-
负责人:Mark T Heise
-
依托单位:
Pathogenesis of Chikungunya virus
-
批准号:8375894
-
项目类别:
-
资助金额:$21.32万
-
财政年份:2012
-
负责人:Mark T Heise
-
依托单位:
TRIM Interactions with Arthritic Alphaviruses
-
批准号:8249185
-
项目类别:
-
资助金额:$21.89万
-
财政年份:2012
-
负责人:Mark T Heise
-
依托单位:
Pathogenesis of Chikungunya virus
-
批准号:8234196
-
项目类别:
-
资助金额:$20.15万
-
财政年份:2011
-
负责人:Mark T Heise
-
依托单位:
Pathogenesis of Chikungunya virus
-
批准号:7671949
-
项目类别:
-
资助金额:$11.31万
-
财政年份:2009
-
负责人:Mark T Heise
-
依托单位:
Togavirus Tropism for Bones, Joints, and CNS
-
批准号:7928648
-
项目类别:
-
资助金额:$21.55万
-
财政年份:2009
-
负责人:Mark T Heise
-
依托单位:
Improved Vaccines for Rift Valley Fever Virus
-
批准号:7473550
-
项目类别:
-
资助金额:$47.3万
-
财政年份:2008
-
负责人:Mark T Heise
-
依托单位:
Improved Vaccines for Rift Valley Fever Virus
-
批准号:7586676
-
项目类别:
-
资助金额:$47.39万
-
财政年份:2008
-
负责人:Mark T Heise
-
依托单位:
Improved Vaccines for Rift Valley Fever Virus
-
批准号:7787472
-
项目类别:
-
资助金额:$45.64万
-
财政年份:2008
-
负责人:Mark T Heise
-
依托单位:
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
-
批准号:7728264
-
项目类别:
-
资助金额:$28.89万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Arbovirus Evasion of Type I Interferon Induction
-
批准号:7202170
-
项目类别:
-
资助金额:$21.75万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Arbovirus Evasion of Type I Interferon Induction
-
批准号:7380005
-
项目类别:
-
资助金额:$17.76万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
-
批准号:8196845
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
-
批准号:7994179
-
项目类别:
-
资助金额:$28.6万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Immune Evasion Mechanisms of Neurovirulent Alphaviruses
-
批准号:7531806
-
项目类别:
-
资助金额:$29.12万
-
财政年份:2007
-
负责人:Mark T Heise
-
依托单位:
Core-- Animal Models
-
批准号:6915414
-
项目类别:
-
资助金额:$29.71万
-
财政年份:2004
-
负责人:Mark T Heise
-
依托单位:
TOGAVIRUS TROPISM FOR BONES, JOINTS, AND CNS
-
批准号:6375362
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2000
-
负责人:Mark T Heise
-
依托单位:
TOGAVIRUS TROPISM FOR BONES, JOINTS, AND CNS
-
批准号:6652043
-
项目类别:
-
资助金额:$23.77万
-
财政年份:2000
-
负责人:Mark T Heise
-
依托单位:
海外基金